# SUMMARY - Phase 3 Iteration 030

## Verdict

`fail`. Final audit-only closure at the planned Phase 3 cap of 30 iterations. No
new strategy was tested, no new trials were consumed, and no deploy or paper-trade
claim is authorized.

## Tested

Parsed the 29 prior Phase 3 `RESULTS.json` files and checked required artifact
presence (`PRE_REG.md`, `RESULTS.json`, `SUMMARY.md`) for iterations 001-029. This
was a closure/control iteration, not an optimization or strategy-family test
`[testing_tuning, p.327-335]`.

## Benchmark Comparison

No benchmark return was recomputed. The audit preserved each source iteration's
pre-registered primary buy-and-hold benchmark and only checked whether saved
statuses could support promotion.

Summary from saved artifacts:

- Parsed iterations: 29/29.
- Status counts: `economic_beater_not_validated=17`, `fail=11`, `data_blocked=1`.
- Prior Phase 3 local `n_trials` sum: `96`.
- This iteration `n_trials=0`; `cumulative_n_trials` remains `312`.

## Gates

- Artifact completeness: pass.
- Zero `winner=true`: pass.
- Zero `strict_winner`: pass.
- Zero `candidate_watchlist`: pass.
- Zero `paper_trade_candidate`: pass.
- All 17 economic beaters blocked by failed or missing strict gates: pass.
- MCPT/PBO/DSR recomputation: not performed; prior saved gates remain binding
  `[testing_tuning, p.318-320]`, `[advances_fin_ml, p.208-211]`,
  `[advances_fin_ml, p.222-223]`.

Kill switches: final audit tests no executable strategy; prior economic beaters
remain blocked by failed or missing strict gates; no automated promotion at Phase 3
cap.

## Lessons

Phase 3 produced multiple full-window economic beaters, but none survived the full
validation stack. The repeated pattern is economically attractive leverage or
high-beta exposure that fails MCPT/DSR/PBO, rolling robustness or stress gates, so
the safe closure is no winner and no deployment.

## Next Step

Do not locally tune the Phase 3 families. Any future restart should require a new
spec/mechanism or restored data scope, with fresh pre-registration and cumulative
trial accounting.

## Ambiguity Note

The worktree contained pre-existing modified public docs and Phase 3 artifacts.
This iteration did not revert or rewrite unrelated changes and followed the
user-supplied state plus `MEMORY.md`.
